Company / R&D Expense
ENvue Medical, Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$909.0K
FY2025
5-year range
$171.0K / $909.0K
FY2021-FY2025
Trend
+391.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense changed +391% YoY in FY2025, a notable deviation from the 9-year average annual change of +44%.
Based on SEC 10-K filings.
$909,000 in FY2025 with a 5-year CAGR of +12.1%.
Improved from $283,000 to $909,000 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +45.8%
- 5-Year CAGR
- +12.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +12.1%, indicating consistent growth.
- In FY2025, r&d expense increased 391.4% year-over-year.
- Lowest r&d expense in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $909.0K | +391.4% |
| FY2024 | $185.0K | -34.6% |
| FY2023 | $283.0K | -3.4% |
| FY2022 | $293.0K | +71.3% |
| FY2021 | $171.0K | -66.7% |
| FY2020 | $514.0K | -16.3% |
| FY2019 | $614.0K | -11.4% |
| FY2018 | $693.0K | +18.7% |
| FY2017 | $584.0K | +46.4% |
| FY2016 | $399.0K | -7.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026